FSHD Diaphragm Ultrasound Study
Part of Bones, joints & muscles, Genetic & congenital clinical trials.
This study uses ultrasound to look at the diaphragm in people with FSHD. It aims to better understand how FSHD affects breathing muscles over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed genetic diagnosis of FSHD.
- You must be 18 years or older.
- You need to be able to sign a consent form to participate.
- You should not have had any neck or chest injury, surgery, or radiation that could damage the main nerve to your diaphragm.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study creates a patient-driven health and research platform for people with FSHD. It aims to collect information to better understand the condition and improve future research and care.
This study uses a special ultrasound (elastography) to look at the diaphragm in children with a congenital diaphragmatic hernia (CDH) and compare it to children without diaphragm problems. The goal is to better understand the diaphragm's health after CDH repair.
This is a study that follows people who have a confirmed FSHD1 genetic change (and some healthy people for comparison). It may help researchers better understand the condition and how it affects people over time.
This trial studies how well certain physical/movement tests work in people with facioscapulohumeral muscular dystrophy (FSHD). It may help clinicians measure changes more accurately and tailor care over time.
This trial uses ultrasound (a non-painful scanning method) to measure how well the diaphragm works around the time of surgery. It aims to learn whether diaphragm changes during surgery relate to breathing problems, especially in people undergoing abdominal, pelvic, or vascular operations.
This study uses a bedside ultrasound to check the diaphragm muscle in people with liver cirrhosis. It aims to predict complications like fluid buildup and muscle loss, especially in settings with limited resources.
Hear when a new FSHD1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.